Novartis India Ltd

NOVARTIND
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,869 cr, stock is ranked 743
Moderate RiskStock is 2.90x as volatile as Nifty
789.8532.45 (+4.28%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,869 cr, stock is ranked 743
Moderate RiskStock is 2.90x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
89.44
PB RatioPB Ratio
2.63
Dividend YieldDiv. Yield
1.32%
Sector PESector PE
38.41
Sector PBSector PB
5.14
Sector Div YldSctr Div Yld
0.67%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Novartis India Limited manufactures drugs, medicines and allied products. The Company is engaged in the wholesale of pharmaceuticals and medical goods.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021735.72568.94474.39414.4478.3651.7710.0820.90
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Cash Dividend 
Ex. DateAug 17, 2021

Final • Div/Share: ₹ 10

See all events